Literature DB >> 26428498

Epigenetic regulation of human placental function and pregnancy outcome: considerations for causal inference.

Vania Januar1, Gernot Desoye2, Boris Novakovic1, Silvija Cvitic2, Richard Saffery3.   

Abstract

Epigenetic mechanisms, often defined as regulating gene activity independently of underlying DNA sequence, are crucial for healthy development. The sum total of epigenetic marks within a cell or tissue (the epigenome) is sensitive to environmental influence, and disruption of the epigenome in utero has been associated with adverse pregnancy outcomes. Not surprisingly, given its multifaceted functions and important role in regulating pregnancy outcome, the placenta shows unique epigenetic features. Interestingly however, many of these are only otherwise seen in human malignancy (the pseudomalignant placental epigenome). Epigenetic variation in the placenta is now emerging as a candidate mediator of environmental influence on placental functioning and a key regulator of pregnancy outcome. However, replication of findings is generally lacking, most likely due to small sample sizes and a lack of standardization of analytical approaches. Defining DNA methylation "signatures" in the placenta associated with maternal and fetal outcomes offers tremendous potential to improve pregnancy outcomes, but care must be taken in interpretation of findings. Future placental epigenetic research would do well to address the issues present in epigenetic epidemiology more generally, including careful consideration of sample size, potentially confounding factors, issues of tissue heterogeneity, reverse causation, and the role of genetics in modulating epigenetic profile. The importance of animal or in vitro models in establishing a functional role of epigenetic variation identified in human beings, which is key to establishing causation, should not be underestimated.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DNA methylation; Developmental Origins of Health and Disease; confounding; development; epigenetics; epigenome; fetal programming; gestational age; gestational diabetes; intrauterine growth restriction; placenta; preeclampsia; pseudomalignant; reverse causation; trophoblast

Mesh:

Year:  2015        PMID: 26428498     DOI: 10.1016/j.ajog.2015.07.011

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  36 in total

Review 1.  Prenatal substance exposure and offspring development: Does DNA methylation play a role?

Authors:  Valerie S Knopik; Kristine Marceau; L Cinnamon Bidwell; Emily Rolan
Journal:  Neurotoxicol Teratol       Date:  2018-02-16       Impact factor: 3.763

2.  Extremely low gestational age and very low birthweight for gestational age are risk factors for autism spectrum disorder in a large cohort study of 10-year-old children born at 23-27 weeks' gestation.

Authors:  Robert M Joseph; Steven J Korzeniewski; Elizabeth N Allred; T Michael O'Shea; Tim Heeren; Jean A Frazier; Janice Ware; Deborah Hirtz; Alan Leviton; Karl Kuban
Journal:  Am J Obstet Gynecol       Date:  2016-11-12       Impact factor: 8.661

3.  The impact of tobacco chemicals and nicotine on placental development.

Authors:  Melissa A Suter; Kjersti M Aagaard
Journal:  Prenat Diagn       Date:  2020-02-11       Impact factor: 3.050

4.  Reciprocal upregulation of hypoxia-inducible factor-1α and persistently enhanced placental adenosine signaling contribute to the pathogenesis of preeclampsia.

Authors:  Takayuki Iriyama; Wei Wang; Nicholas F Parchim; Seisuke Sayama; Keiichi Kumasawa; Takeshi Nagamatsu; Anren Song; Yang Xia; Rodney E Kellems
Journal:  FASEB J       Date:  2020-01-12       Impact factor: 5.191

5.  Sexual epigenetic dimorphism in the human placenta: implications for susceptibility during the prenatal period.

Authors:  Elizabeth Martin; Lisa Smeester; Paige A Bommarito; Matthew R Grace; Kim Boggess; Karl Kuban; Margaret R Karagas; Carmen J Marsit; T Michael O'Shea; Rebecca C Fry
Journal:  Epigenomics       Date:  2017-02-17       Impact factor: 4.778

6.  The green tea polyphenol EGCG alleviates maternal diabetes-induced neural tube defects by inhibiting DNA hypermethylation.

Authors:  Jianxiang Zhong; Cheng Xu; E Albert Reece; Peixin Yang
Journal:  Am J Obstet Gynecol       Date:  2016-03-12       Impact factor: 8.661

Review 7.  Reduced DHA transfer in diabetic pregnancies: mechanistic basis and long-term neurodevelopmental implications.

Authors:  Michelle P Judge; Sharon G Casavant; Juliana A M Dias; Jacqueline M McGrath
Journal:  Nutr Rev       Date:  2016-05-03       Impact factor: 7.110

Review 8.  Placental programming of neuropsychiatric disease.

Authors:  Panagiotis Kratimenos; Anna A Penn
Journal:  Pediatr Res       Date:  2019-04-19       Impact factor: 3.756

Review 9.  Developmental origins of metabolic diseases.

Authors:  Daniel J Hoffman; Theresa L Powell; Emily S Barrett; Daniel B Hardy
Journal:  Physiol Rev       Date:  2020-12-03       Impact factor: 46.500

10.  Maternal eNOS deficiency determines a fatty liver phenotype of the offspring in a sex dependent manner.

Authors:  Berthold Hocher; Hannah Haumann; Jan Rahnenführer; Christoph Reichetzeder; Philipp Kalk; Thiemo Pfab; Oleg Tsuprykov; Stefan Winter; Ute Hofmann; Jian Li; Gerhard P Püschel; Florian Lang; Detlef Schuppan; Matthias Schwab; Elke Schaeffeler
Journal:  Epigenetics       Date:  2016-05-13       Impact factor: 4.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.